
Kardigan
Heart health company aiming to make cardiovascular disease preventable and curable with innovative drug development.
Related Content
Kardigan is a heart health company dedicated to transforming the landscape of cardiovascular medicine. With a leadership team of seasoned biopharma veterans, the company focuses on making cardiovascular disease preventable and curable. Kardigan operates in the biotechnology sector, targeting patients with cardiovascular conditions. The business model revolves around the discovery and development of multiple important medicines at an unprecedented pace, leveraging their deep expertise in cardiovascular drug development. Kardigan's revenue is generated through the commercialization of these medicines, aiming to address the global challenge of cardiovascular disease, which remains a leading cause of death worldwide. The company is driven by a commitment to modernize the discovery and development process, bringing a high level of focus and passion to their mission.
Keywords: cardiovascular, heart health, drug development, biotechnology, biopharma, medicine, disease prevention, curable, leadership, expertise
Tech stack
Investments by Kardigan
Edit